R&D Innovation

Research Platform

Hebei Shengxue Dacheng Pharmaceutical Co., Ltd

The Company’s R&D Center was established in 2006, consisting of the Technology Research Center, Product Development Center, R&D Management Center and Analysis & Testing Center.Its research scope covers microbial breeding, fermentation process development, refining process optimization, chemical synthesis technology, analytical and testing technology, and other fields. Product development focuses on specialty human APIs and preparations, animal health products, pet medicines, and general health products.

Innovation Infrastructure

Core Synthesis Platforms

High-precision infrastructure dedicated to molecular discovery and industrial precursor refinement.

Technical Validation Hub

Integrated safety and purity protocols ensuring consistent batch-to-batch chemical integrity.

Partner Integration System

Dedicated technical gateways for industrial manufacturers managing specialized project data.

The R&D Center has been accredited as a Grade A R&D Institution for industrial enterprises in Hebei Province, and hosts the Hebei Provincial Postdoctoral Innovation Practice Base. It currently employs more than 60 full-time R&D staff, among which doctors and masters account for over 45%. The center occupies over 2,000 square meters of scientific research and office space, equipped with more than 360 sets of experimental instruments and professional equipment.